1.
Australas J Dermatol
; 65(1): 63-66, 2024 Feb.
Article
in English
| MEDLINE
| ID: mdl-37929636
ABSTRACT
Evidence of effectiveness and safety in combined therapies is scarce and based on case reports and small case series. We report a case of dual biologic therapy with ustekinumab and dupilumab in a patient with severe Crohn disease and atopic dermatitis. There was no interference between these drugs after a 7-month follow-up.
Subject(s)
Antibodies, Monoclonal, Humanized , Crohn Disease , Dermatitis, Atopic , Humans , Antibodies, Monoclonal/therapeutic use , Ustekinumab/therapeutic use , Dermatitis, Atopic/drug therapy , Crohn Disease/drug therapy , Treatment Outcome , Severity of Illness Index
2.
J Dermatol
; 50(12): 1650-1652, 2023 12.
Article
in English
| MEDLINE
| ID: mdl-37870261